{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:17:30Z","timestamp":1790713050014,"version":"4.1.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institute","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Understanding determinants of antibiotic use during pregnancy is crucial for optimizing their utilization in clinical practice. We aimed to investigate which individual-level factors are associated with antibiotic use among pregnant women.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Population-based cohort study using linked data from the Swedish national health and population registers spanning from 2006 to 2019. Sociodemographic characteristics, medical and obstetric history, lifestyle and healthcare utilization were investigated as independent variables. Any systemic antibiotic use during pregnancy, the primary outcome, was determined from filled prescriptions, with broad-spectrum antibiotics and multiple courses of antibiotics as secondary outcomes. Multiple logistic regression was used to estimate odds ratios (ORs), including all independent variables in the model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Among 20 variables associated with any systemic antibiotic use during pregnancy, preconception prescription drug use (OR 1.93 [95% CI 1.87\u20131.98] for &gt;\u20094 vs. 0\u20131 unique therapeutic subgroups), chronic renal disease (1.82 [1.73\u20131.93]) and low maternal age (1.67 [1.61\u20131.74] for ages\u2009&lt;\u200920 vs. 30\u201334 years) had the highest odds. Chronic renal disease, immunodeficiency disorders and preconception drug use (&gt;\u20094 vs. 0\u20131 therapeutic subgroups) had the highest odds of broad-spectrum antibiotic use and use of multiple antibiotic courses.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Pre-existing morbidities and low maternal age were most strongly associated with antibiotic use during pregnancy, suggesting a needs-based approach in prescribing. Proactive management of morbidities and infection prevention strategies, particularly targeting young women of reproductive age, could potentially reduce the need for antibiotic treatment in prenatal care.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-025-07736-4","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:57:05Z","timestamp":1750345025000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Factors associated with antibiotic use during pregnancy in Sweden: a population-based cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Aya Olivia","family":"Nakitanda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Pazzagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingvild","family":"Odsbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"issue":"15","key":"7736_CR1","doi-asserted-by":"publisher","first-page":"E3463","DOI":"10.1073\/pnas.1717295115","volume":"115","author":"EY Klein","year":"2018","unstructured":"Klein EY, Van Boeckel TP, Martinez EM, et al. Global increase and geographic convergence in antibiotic consumption between 2000 and 2015. Proc Natl Acad Sci USA. 2018;115(15):E3463\u201370.","journal-title":"Proc Natl Acad Sci USA"},{"key":"7736_CR2","doi-asserted-by":"publisher","first-page":"113497","DOI":"10.1016\/j.ijheh.2020.113497","volume":"226","author":"D Schmiege","year":"2020","unstructured":"Schmiege D, Evers M, Kistemann T, Falkenberg T. What drives antibiotic use in the community? A systematic review of determinants in the human outpatient sector. Int J Hyg Environ Health. 2020;226:113497.","journal-title":"Int J Hyg Environ Health"},{"issue":"1","key":"7736_CR3","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.cmi.2018.04.031","volume":"25","author":"V Zanichelli","year":"2019","unstructured":"Zanichelli V, Tebano G, Gyssens IC, et al. Patient-related determinants of antibiotic use: a systematic review. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2019;25(1):48\u201353.","journal-title":"Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis"},{"issue":"3","key":"7736_CR4","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ijantimicag.2012.09.003","volume":"41","author":"A Teixeira Rodrigues","year":"2013","unstructured":"Teixeira Rodrigues A, Roque F, Falc\u00e3o A, Figueiras A, Herdeiro MT. Understanding physician antibiotic prescribing behaviour: a systematic review of qualitative studies. Int J Antimicrob Agents. 2013;41(3):203\u201312.","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"7736_CR5","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3109\/00365548.2014.954264","volume":"46","author":"A Ternhag","year":"2014","unstructured":"Ternhag A, Gr\u00fcnewald M, Naucl\u00e9r P, Wisell KT. Antibiotic consumption in relation to socio-demographic factors, co-morbidity, and accessibility of primary health care. Scand J Infect Dis. 2014;46(12):888\u201396.","journal-title":"Scand J Infect Dis"},{"key":"7736_CR6","unstructured":"Public Health Agency of Sweden, National Veterinary Institute. Swedres-Svarm 2019. Sales of antibiotics and occurrence of resistance in Sweden. Solna\/Uppsala. 2019."},{"issue":"11","key":"7736_CR7","doi-asserted-by":"publisher","first-page":"764","DOI":"10.2471\/BLT.16.184374","volume":"95","author":"S M\u00f6lstad","year":"2017","unstructured":"M\u00f6lstad S, L\u00f6fmark S, Carlin K, et al. Lessons learnt during 20 years of the Swedish strategic programme against antibiotic resistance. Bull World Health Organ. 2017;95(11):764\u201373.","journal-title":"Bull World Health Organ"},{"issue":"7","key":"7736_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1111\/aogs.13570","volume":"98","author":"E Wolgast","year":"2019","unstructured":"Wolgast E, Lindh-\u00c5strand L, Lilliecreutz C. Women\u2019s perceptions of medication use during pregnancy and breastfeeding-A Swedish cross-sectional questionnaire study. Acta Obstet Gynecol Scand. 2019;98(7):856\u201364.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"2","key":"7736_CR9","doi-asserted-by":"publisher","first-page":"bjgpopen18X1015","DOI":"10.3399\/bjgpopen18X101505","volume":"2","author":"GH Fossum","year":"2018","unstructured":"Fossum GH, Gjelstad S, Kv\u00e6rner KJ, Lindbaek M. Prescribing antibiotics when the stakes are higher - do gps prescribe less when patients are pregnant? A retrospective observational study. BJGP Open. 2018;2(2):bjgpopen18X101505.","journal-title":"BJGP Open"},{"issue":"5","key":"7736_CR10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/pds.1225","volume":"15","author":"U Amann","year":"2006","unstructured":"Amann U, Egen-Lappe V, Strunz-Lehner C, Hasford J. Antibiotics in pregnancy: analysis of potential risks and determinants in a large German statutory sickness fund population. Pharmacoepidemiol Drug Saf. 2006;15(5):327\u201337.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"7736_CR11","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1111\/1471-0528.12806","volume":"121","author":"A Broe","year":"2014","unstructured":"Broe A, Pottegard A, Lamont RF, Jorgensen JS, Damkier P. Increasing use of antibiotics in pregnancy during the period 2000\u20132010: prevalence, timing, category, and demographics. BJOG: Int J Obstet Gynecol. 2014;121(8):988\u201396.","journal-title":"BJOG: Int J Obstet Gynecol"},{"issue":"12","key":"7736_CR12","doi-asserted-by":"publisher","first-page":"e050569","DOI":"10.1136\/bmjopen-2021-050569","volume":"11","author":"NTH Trinh","year":"2021","unstructured":"Trinh NTH, Hjorth S, Nordeng HME. Use of interrupted time-series analysis to characterise antibiotic prescription fills across pregnancy: a Norwegian nationwide cohort study. BMJ Open. 2021;11(12):e050569.","journal-title":"BMJ Open"},{"issue":"12","key":"7736_CR13","doi-asserted-by":"publisher","first-page":"e82932","DOI":"10.1371\/journal.pone.0082932","volume":"8","author":"J Stokholm","year":"2013","unstructured":"Stokholm J, Schjorring S, Pedersen L, et al. Prevalence and predictors of antibiotic administration during pregnancy and birth. PLoS ONE. 2013;8(12):e82932.","journal-title":"PLoS ONE"},{"key":"7736_CR14","doi-asserted-by":"crossref","unstructured":"Tran A, Zureik M, Sibiude J, et al. Prevalence and associated factors of antibiotic exposure during pregnancy in a large French population-based study during the 2010-19 period. J Antimicrob Chemother. 2023;78(10):2535\u201343.","DOI":"10.1093\/jac\/dkad266"},{"issue":"3","key":"7736_CR15","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/aogs.14741","volume":"103","author":"AO Nakitanda","year":"2024","unstructured":"Nakitanda AO, Odsbu I, Pasternak B, Karlsson P, Pazzagli L. Antibiotic use during pregnancy in Sweden: A nationwide utilization study covering 2007\u20132019. Acta Obstet Gynecol Scand. 2024;103(3):531\u20139.","journal-title":"Acta Obstet Gynecol Scand"},{"key":"7736_CR16","doi-asserted-by":"crossref","unstructured":"Cnattingius S, K\u00e4ll\u00e9n K, Sandstr\u00f6m A, et al. The Swedish medical birth register during five decades: documentation of the content and quality of the register. Eur J Epidemiol. 2023;38(1):109\u201320.","DOI":"10.1007\/s10654-022-00947-5"},{"key":"7736_CR17","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1186\/1471-2458-11-450","volume":"11","author":"JF Ludvigsson","year":"2011","unstructured":"Ludvigsson JF, Andersson E, Ekbom A, et al. External review and validation of the Swedish National inpatient register. BMC Public Health. 2011;11:450.","journal-title":"BMC Public Health"},{"key":"7736_CR18","unstructured":"WHO Collaborating Centre for Drug Statistics Methodology. ATC classification index with DDDs. In. Oslo, Norway 2024."},{"issue":"7","key":"7736_CR19","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/pds.1294","volume":"16","author":"B Wettermark","year":"2007","unstructured":"Wettermark B, Hammar N, Fored CM, et al. The new Swedish prescribed drug Register\u2013opportunities for pharmacoepidemiological research and experience from the first six months. Pharmacoepidemiol Drug Saf. 2007;16(7):726\u201335.","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"2","key":"7736_CR20","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","volume":"31","author":"JF Ludvigsson","year":"2016","unstructured":"Ludvigsson JF, Almqvist C, Bonamy AK, et al. Registers of the Swedish total population and their use in medical research. Eur J Epidemiol. 2016;31(2):125\u201336.","journal-title":"Eur J Epidemiol"},{"issue":"4","key":"7736_CR21","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1007\/s10654-019-00511-8","volume":"34","author":"JF Ludvigsson","year":"2019","unstructured":"Ludvigsson JF, Svedberg P, Ol\u00e9n O, Bruze G, Neovius M. The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research. Eur J Epidemiol. 2019;34(4):423\u201337.","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"7736_CR22","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/s10654-022-00947-5","volume":"38","author":"S Cnattingius","year":"2023","unstructured":"Cnattingius S, K\u00e4ll\u00e9n K, Sandstr\u00f6m A, et al. The Swedish medical birth register during five decades: Documentation of the content and quality of the register. Eur J Epidemiol. 2023;38(1):109\u201320.","journal-title":"Eur J Epidemiol"},{"issue":"3","key":"7736_CR23","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1177\/1403494820981496","volume":"50","author":"M Wemrell","year":"2022","unstructured":"Wemrell M, Lenander C, Hansson K, Perez RV, Hedin K, Merlo J. Socio-economic disparities in the dispensation of antibiotics in Sweden 2016\u20132017: an intersectional analysis of individual heterogeneity and discriminatory accuracy. Scand J Public Health. 2022;50(3):347\u201354.","journal-title":"Scand J Public Health"},{"issue":"1","key":"7736_CR24","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/s12877-017-0621-2","volume":"17","author":"N Masnoon","year":"2017","unstructured":"Masnoon N, Shakib S, Kalisch-Ellett L, Caughey GE. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017;17(1):230.","journal-title":"BMC Geriatr"},{"key":"7736_CR25","unstructured":"R Core Team. R: A language and environment for statistical computing. 2022.https:\/\/www.R-project.org\/"},{"issue":"10","key":"7736_CR26","first-page":"e05017","volume":"15","author":"ECDC (European Centre for Disease Prevention and Control), EFSA BIOHAZ Panel (European Food Safety Authority Panel on Biological Hazards), CVMP (EMA Committee for Medicinal Products for Veterinary Use)","year":"2017","unstructured":"ECDC (European Centre for Disease Prevention and Control), EFSA BIOHAZ Panel (European Food Safety Authority Panel on Biological Hazards), CVMP (EMA Committee for Medicinal Products for Veterinary Use). ECDC, EFSA and EMA joint scientific opinion on a list of outcome indicators as regards surveillance of antimicrobial resistance and antimicrobial consumption in humans and food-producing animals. EFSA J Eur Food Saf Auth. 2017;15(10):e05017.","journal-title":"EFSA J Eur Food Saf Auth"},{"issue":"11","key":"7736_CR27","first-page":"Cd008995","volume":"11","author":"D Ameratunga","year":"2023","unstructured":"Ameratunga D, Yazdani A, Kroon B. Antibiotics prior to or at the time of embryo transfer in ART. Cochrane Database Syst Rev. 2023;11(11):Cd008995.","journal-title":"Cochrane Database Syst Rev"},{"issue":"6","key":"7736_CR28","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1016\/j.amepre.2015.11.009","volume":"50","author":"MB Steinberg","year":"2016","unstructured":"Steinberg MB, Akincigil A, Kim EJ, Shallis R, Delnevo CD. Tobacco smoking as a risk factor for increased antibiotic prescription. Am J Prev Med. 2016;50(6):692\u20138.","journal-title":"Am J Prev Med"},{"issue":"2","key":"7736_CR29","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1467-789X.2008.00541.x","volume":"10","author":"MR Torloni","year":"2009","unstructured":"Torloni MR, Betr\u00e1n AP, Horta BL, et al. Prepregnancy BMI and the risk of gestational diabetes: a systematic review of the literature with meta-analysis. Obes Reviews: Official J Int Association Study Obes. 2009;10(2):194\u2013203.","journal-title":"Obes Reviews: Official J Int Association Study Obes"},{"issue":"11","key":"7736_CR30","doi-asserted-by":"publisher","first-page":"4241","DOI":"10.1111\/bcp.14840","volume":"87","author":"YS Rosenthal","year":"2021","unstructured":"Rosenthal YS, Rosenthal A, Shalev Ram H, Ram S, Chodick G, Koren G. Association between oral contraceptives and serious infections: A population-based cohort study. Br J Clin Pharmacol. 2021;87(11):4241\u201351.","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"7736_CR31","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1080\/02770903.2021.1993247","volume":"59","author":"BM Snyder","year":"2022","unstructured":"Snyder BM, Patterson MF, Gebretsadik T, et al. Association between asthma status and prenatal antibiotic prescription fills among women in a medicaid population. J Asthma: Official J Association Care Asthma. 2022;59(10):2100\u20137.","journal-title":"J Asthma: Official J Association Care Asthma"},{"issue":"5","key":"7736_CR32","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.ajog.2021.10.037","volume":"226","author":"S Al Khalaf","year":"2022","unstructured":"Al Khalaf S, Bodunde E, Maher GM, et al. Chronic kidney disease and adverse pregnancy outcomes: a systematic review and meta-analysis. Am J Obstet Gynecol. 2022;226(5):656\u2013e670632.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7736_CR33","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s10157-018-1641-8","volume":"23","author":"J Ishigami","year":"2019","unstructured":"Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23(4):437\u201347.","journal-title":"Clin Exp Nephrol"},{"issue":"11","key":"7736_CR34","first-page":"3379","volume":"74","author":"MA Borg","year":"2019","unstructured":"Borg MA, Camilleri L. Broad-spectrum antibiotic use in Europe: more evidence of cultural influences on prescribing behaviour. J Antimicrob Chemother. 2019;74(11):3379\u201383.","journal-title":"J Antimicrob Chemother"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07736-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07736-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T14:57:09Z","timestamp":1750345029000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07736-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7736"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07736-4","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"assertion":[{"value":"20 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Regional Ethics Committee in Stockholm (Dnr: 2015\/1826-31\/2 with amendments 2017\/2238-32, 2018\/1790-32, 2018\/2211-32). Consent for inclusion in the Swedish national registers and participation in register-based studies was waived in accordance with the Swedish Act on ethical review of research relating to humans. The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"AON is an employee of the Centre for Pharmacoepidemiology at Karolinska Institutet which receives funding from different entities including regulatory authorities, pharmaceutical companies and contract research organizations to conduct drug safety and drug utilization studies, unrelated to this work. The other authors report no conflicts of interest in connection with this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"672"}}